Abstract
BackgroundRegulatory T cell (Tregs) inhibit activity of anti-tumor T cells, and have been shown to limit checkpoint inhibitor effectiveness. Depletion of Tregs seems desirable during immunotherapy, but chronic Treg depletion...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have